Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1–Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial

Objectives. Evaluation of pharmacokinetics and pharmacodynamics of darunavir and etravirine among HIV-1–infected, treatment-experienced adults from GRACE, by sex and race. Methods. Patients received darunavir/ritonavir 600/100mg twice daily plus other antiretrovirals, which could include etravirine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakuda, Thomas, Sekar, Vanitha, Vis, Peter, Coate, Bruce, Ryan, Robert, Anderson, David, De La Rosa, Guy, Mrus, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318205/
https://www.ncbi.nlm.nih.gov/pubmed/22536495
http://dx.doi.org/10.1155/2012/186987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318205/
https://www.ncbi.nlm.nih.gov/pubmed/22536495
http://dx.doi.org/10.1155/2012/186987

Ejemplares similares